Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Jan 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2026Option exercise(M)1K$0.06$651K
Jan 14, 2026Sell(S)1K$2.50$3K0
Jan 13, 2026Sell(S)5K$2.50$14K0
Jan 13, 2026Option exercise(M)5K$0.06$3255K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2026Option exercise(M)1K—$0333K
Jan 13, 2026Option exercise(M)5K—$0334K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Serina Therapeutics, Inc.

Build

Ask your agent about SER insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001301120-26-000004"
Ask your agent
Use Arkolith to summarize insider buying and selling at Serina Therapeutics, Inc.
over the last 90 days and cite the filings.